Last edition
News about "Acute Kidney Injury "
Arch Biopartners Advances Phase II Trial of LSALT Peptide as New Site Begins Patient Dosing
Arch Biopartners advances LSALT peptide trial for acute kidney injury as new clinical site initiates patient dosing and global expansion plans progress.
Acute Kidney Injury | 24/03/2026 | By News Bureau
Saghmos Gets US Patent for Phase 3-Ready Cardiorenal Metabolic Modulator
Saghmos Therapeutics, Inc. has announced that the US Patent and Trademark Office (USPTO) has granted US Patent No. 11,986,473 titled, 'Prevention and/or Treatment of Contrast-Induced Acute Kidney Injury' for its Phase 3-ready product, ST-62516.
Acute Kidney Injury | 06/06/2024 | By Aishwarya | 564
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy